当前位置:科学网首页 > 小柯机器人 >详情
RN7SL1可增强CAR-T 细胞免疫功能
作者:小柯机器人 发布时间:2021/8/31 14:48:20

美国宾夕法尼亚大学Andy J. Minn和Carl H. June课题组合作揭示了免疫刺激RNA RN7SL1使嵌合抗原受体 (CAR)-T细胞增强自主和内源性免疫功能。相关论文发表在2021年8月30日出版的《细胞》杂志上。

他们设计 CAR-T 细胞以传递 RN7SL1,这是一种内源性 RNA,可激活 RIG-I / MDA5 信号传导。RN7SL1 促进 CAR-T 细胞的扩增和效应记忆分化。此外,RN7SL1 被部署在细胞外囊泡中并选择性地转移到免疫细胞。与其他 RNA 激动剂不同,转移的 RN7SL1 限制了骨髓源性抑制细胞 (MDSC) 的发育,减少了骨髓细胞中的 TGFB,并促进了具有共刺激特征的树突状细胞 (DC) 亚群。因此,内源性效应记忆和肿瘤特异性 T 细胞也会扩增,从而排斥具有 CAR 抗原丢失的实体瘤。

在改善的内源性免疫的支持下,CAR-T 细胞现在可以与 RN7SL1 共同部署肽抗原以提高疗效,即使在异源 CAR 抗原肿瘤缺乏足够的新抗原时也是如此。

据了解,肿瘤浸润不良、衰竭进展和抗原不足是限制CAR-T 细胞功效的常见机制。递送模式识别受体激动剂是改善免疫功能的一种策略;然而,将这些激动剂靶向免疫细胞具有挑战性,并且癌细胞中的脱靶信号可能是有害的。

附:英文原文

Title: The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function

Author: Lexus R. Johnson, Daniel Y. Lee, Jacqueline S. Eacret, Darwin Ye, Carl H. June, Andy J. Minn

Issue&Volume: 2021-08-30

Abstract: Poor tumor infiltration, development of exhaustion, and antigen insufficiency arecommon mechanisms that limit chimeric antigen receptor (CAR)-T cell efficacy. Deliveryof pattern recognition receptor agonists is one strategy to improve immune function;however, targeting these agonists to immune cells is challenging, and off-target signalingin cancer cells can be detrimental. Here, we engineer CAR-T cells to deliver RN7SL1,an endogenous RNA that activates RIG-I/MDA5 signaling. RN7SL1 promotes expansion andeffector-memory differentiation of CAR-T cells. Moreover, RN7SL1 is deployed in extracellularvesicles and selectively transferred to immune cells. Unlike other RNA agonists, transferredRN7SL1 restricts myeloid-derived suppressor cell (MDSC) development, decreases TGFBin myeloid cells, and fosters dendritic cell (DC) subsets with costimulatory features.Consequently, endogenous effector-memory and tumor-specific T cells also expand, allowingrejection of solid tumors with CAR antigen loss. Supported by improved endogenousimmunity, CAR-T cells can now co-deploy peptide antigens with RN7SL1 to enhance efficacy,even when heterogenous CAR antigen tumors lack adequate neoantigens.

DOI: 10.1016/j.cell.2021.08.004

Source: https://www.cell.com/cell/fulltext/S0092-8674(21)00946-6

期刊信息
Cell:《细胞》,创刊于1974年。隶属于细胞出版社,最新IF:36.216
官方网址:https://www.cell.com/